All posts by medical

Alphabet, Amazon, Broadcom, Gap and Campbell Soup are part of Zacks Earnings Preview – Yahoo Finance

For Immediate Release

Chicago, IL June 1, 2020 Zacks.com releases the list of companies likely to issue earnings surprises. This weeks list includes Alphabet GOOGL, Amazon AMZN, Broadcom AVGO, Gap GPS and Campbell Soup CPB.

3 Reasons Why the Coronavirus Economic Recovery Will Be Quick

There is no question that the Covid-19 pandemic has pushed the U.S. economy into a severe downturn, ending the longest economic expansion in the nations history. All indicators suggest that this recession will be unlike any we have experienced in the past, with a sharp downturn in economic activities and employment, followed by a reasonably quick recovery.

There are three reasons why I am confident that the U.S. economy will quickly bounce back.

First, the U.S. economy entered this downturn in a very good shape, with consumer and business confidence and employment levels at or near record levels. The expansion preceding the downturn had been the longest in the nations history, but there were visible and obvious imbalances or dislocations that are typically associated with the later stages of economic expansion.

For example, the last two economic recessions followed big bubbles in the housing and Technology sectors. The banking sector that got hit hard in the last recession because of housing exposure remains in excellent shape, with plenty of capital cushion to absorb the cyclical losses that typically incur during downturns (loan-loss reserves).

The Technology sector has emerged as the crown jewel of the U.S. economy, distinguishing the country from all other developed economies. In fact, many of the U.S.- based Technology firms like Alphabet, Amazon, and many others have been critical to keeping all of us engaged and functional in these pandemic-driven shelter-in-place policies.

Second, this is no normal recession that arrived as a result of imbalances in the economy or Fed action. External shocks can cause normal recessions as well, like the one the western world experienced after the oil shock of the early 1970s or results from wars or other armed conflicts.

The Covid-19 pandemic is an external shock that is unique and without precedent, the last such calamity hit us literally a century ago.

The engineered economic shutdown pushed the economy into a recession, but it was a necessary act to slow the spread of the virus and reset human behavior. With most states at different stages of reopening their economies, we can expect economic activity to steadily start resuming. In this outlook, June will be better than May, with May better than April, which was most likely the downturns bottom.

The shelter-in-place pause of the last two months has trained us how to navigate this virus-infested environment as normal economic and human activities resume in the days ahead, even though a cure or vaccine is still some ways off. The pause has undoubtedly been painful, but the generous policy response has more than made up for it.

Third, the policy response has been unprecedented, both in terms of size as well as reach. Actions by the U.S. Congress, the Treasury, and the Fed has ensured that short-term liquidity problems dont become systemic solvency issues that will hobble the economy for a long time.

Congress may need to do more in the coming weeks and months, but the U.S. authorities whatever-it-takes attitude has provided the necessary bridge to the other side of this pandemic.

Full normalcy will only resume after we have a vaccine or cure, absent which economic activity in the leisure, hospitality and transportation areas will remain constrained. As such, I am not projecting the U.S. economy and labor market getting back to pre-Covid levels this year. That said, the worst of the Covid-driven economic pain is already behind us, with things steadily improving in the days ahead.

Growth is expected to resume next year, with full-year 2021 earnings for the S&P 500 index currently expected to be up +26.5% relative to the still-declining 2020 estimates. But as strong as next years growth estimate is, total index earnings would still havent gotten back to pre-Covid levels.

In other words, S&P 500 earnings in 20201 are currently expected to be modestly below the 2019 level.

These numbers translate to an index EPS of $155.54 in 2021 vs. $122.93 in 2020 and $160.96 in 2019.

Story continues

Q1 Earnings Season Scorecard

The Q1 earnings season has effectively come to an end, with results from 490 S&P 500 members already out. Total earnings for these companies are down -13.3% from the same period last year on +1.3% higher revenues, with 66.3% beating EPS and 57.6% beating revenue estimates.

We have another 5 S&P 500 members on deck to report results this week. This weeks docket includes results from chipmaker Broadcom, Gap, Campbell Soup and others.

The comparison charts below put the results from these 490 index members in a historical context. The first set of two charts compare the earnings and revenue growth rates for these companies.

The second set compares the proportion of these companies beating EPS and revenue estimates.

The earnings growth comparisons start looking a lot better when seen on an ex-Finance basis.

For an in-depth look at the overall earnings picture and expectations for the coming quarters, please check out our weekly Earnings Trends report>>>> Covid-19 & Corporate Earnings

The Hottest Tech Mega-Trend of All

Last year, it generated $24 billion in global revenues. By 2020, it's predicted to blast through the roof to $77.6 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.

See Zacks' 3 Best Stocks to Play This Trend >>

Join us on Facebook: https://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com

https://www.zacks.com

Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. http://www.zacks.com/disclaimer.

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss.This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumedthat any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein andis subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performancefor information about the performance numbers displayed in this press release.

Click to get this free report Amazon.com, Inc. (AMZN) : Free Stock Analysis Report The Gap, Inc. (GPS) : Free Stock Analysis Report Campbell Soup Company (CPB) : Free Stock Analysis Report Broadcom Inc. (AVGO) : Free Stock Analysis Report Alphabet Inc. (GOOGL) : Free Stock Analysis Report To read this article on Zacks.com click here.

Read more:
Alphabet, Amazon, Broadcom, Gap and Campbell Soup are part of Zacks Earnings Preview - Yahoo Finance

Long after the illness is gone, the damage from coronavirus may remain – San Francisco Chronicle

The roulette wheel of infection that determines which COVID-19 patients live and die has gripped the world in fear, but researchers are looking into another insidious danger that the disease could be inflicting lasting, even permanent, damage on its victims.

Infectious disease specialists have learned that the health problems caused by the coronavirus sometimes linger for months, raising fears that the virus may have long-term consequences for peoples health.

Theres no doubt there has been anecdotal evidence of symptoms lingering for a while, but we dont know if its 1%, 5%, 20% or 50% of the cases, said Jeffrey Martin, a clinical epidemiologist and professor of epidemiology and biostatistics at UCSF. We need to find out how common that is. Its important that we separate the rare anecdotes from the true frequency.

Cases of chronic fatigue, heart problems, lung damage, blood clotting and neurological symptoms like dizziness and confusion have been documented in numerous patients long after the initial symptoms of COVID-19 have gone away.

The discovery of chronic symptoms could have a significant impact on human behavior as divisions erupt around the country over the speed with which businesses, parks, movie theaters and other gathering spots reopen. Boozy beach parties and concerts may not have the same lure for the young and healthy if the bacchanalia includes the prospect of prolonged disease and long-term disability.

It is what happened to Cliff Morrison, 68, of Oakland, who is still suffering from mood swings, headaches, blurry vision, aching joints and other strange symptoms nobody warned him about nearly two months after he first fell ill with COVID-19.

I still have shortness of breath and some of the cough and no energy or strength, said Morrison, a nurse and health care administrator, who contracted the disease through his work. My vision has improved but its still a little blurry. No one told me that it would go on as long as it has.

Morrison, who worked as an AIDS coordinator in the 1980s, is one of 50 patients infected by COVID-19 who are enrolled in a study that Dr. Martin and a team of researchers at UCSF and San Francisco General Hospital are conducting. The investigation, called the Long-term Impact of Infection with Novel Coronavirus, or Liinc, is to determine what symptoms linger and how long the health problems last.

The study subjects, all of whom have been fever-free and tested negative for at least three weeks, were chosen because they had a wide spectrum of symptoms, from mild to severe.

Morrison, who lives alone, said he was very sick, unable to get out of bed except to go to the bathroom for three weeks. Besides being short of breath and feverish, his symptoms included vision problems, confusion and memory problems he said there is a 10-day stretch when he can barely remember anything.

He suffered from unusually intense mood swings, ranging from deep depression to extreme anger. At one point he developed a rash over the lower half of his body that turned into sores, like the chicken pox, lasting two weeks.

Breathing issues, fatigue, lung damage, heart problems, blood clots, dizziness, confusion, memory loss, coughing, fever, headaches, loss of sense of smell, mood swings, blurry vision and aching joints.

In a small percentage of children who had a coronavirus infection, a condition called pediatric multisystem inflammatory syndrome surfaces weeks after exposure to the virus, causing rashes, fevers and heart inflammation and, in a few cases, death.

Martin said the plan is to interview, take blood and saliva samples, and chart lingering health problems in study subjects for up to two years. It is important, he said, because the disease has not been around long enough to determine whether the lingering symptoms represent an abnormally long recovery process or a long-term problem.

It appears from the early evidence that Morrisons case is not unusual. Many recovering coronavirus patients have reported residual problems months after the initial infection, far longer than the experts thought was possible. The World Health Organization says patients with mild cases of COVID-19 should expect a two-week recovery process while severe infections could last up to six weeks before they clear up.

The evidence of more chronic problems is preliminary, but it is mounting.

Studies in China have found that most COVID-19 patients well over 70% showed lesions or patches of irritation in the lungs known as ground glass opacities that could develop into permanent scars, or pulmonary fibrosis.

The SARS-CoV-2 virus that causes the illness is known to target ACE2 receptors, a protein on the surface of human cells that the spiky virus attaches to. Many of the receptors are in the heart muscle. Various studies indicate cardiovascular damage is common, with one study finding it in 12% of patients studied and another showing heart damage in 19% of the patients.

High rates of blood clots have been reported in China and France. Studies in the two countries found that between 5% and 30% of the hospitalized patients suffered strokes, blockages of arteries or pulmonary embolisms, which are obstructions in the lungs.

Tony-nominated Canadian actor Nick Cordero had his right leg amputated after numerous COVID-related blood clots. The Broadway actor has now been in the hospital for about two months, much of that time on a ventilator.

Others have suffered strokes and heart attacks after being declared disease free and discharged from hospitals. The clots, which are likely caused by immune system responses to the infection, can also cause long-term problems, including heart palpitations and severe shortness of breath.

The virus also appears to attack the central nervous system, causing delirium and hallucinations in about a third of the patients in intensive care units. Morrison never had to go to the hospital, but he nevertheless suffered cognitive issues, which have mostly cleared up.

But many of the long-term problems may be a direct result of the severity of the infection. For instance, most critical patients end up suffering from acute respiratory distress syndrome, or ARDS, which is characterized by fluid in the lungs. Previous studies have shown that as many as 20% of ARDS survivors experience long-term cognitive impairment, including concentration and memory lapses, epidemiologists say.

Timothy Henrich, an associate professor of medicine and Martins colleague at UCSF, said lingering problems can be expected in severe cases involving organ dysfunction, clotting and ARDS, but some people with mild cases of COVID-19 have also reported post-infection problems.

Its not clear whether this is only in the severe cases, said Henrich, an infectious disease clinician, virologist and immunologist. This may be happening in a more sub-acute fashion as well, but it needs to be studied.

Recovering COVID-19 victims, including some of Martin and Henrichs colleagues, have reported feeling foggy and having trouble focusing on work. Others say their coughs, fevers and breathing issues have cycled on and off for a month after the initial symptoms.

People have reported coughing up blood, losing their sense of smell, migraine-like headaches and short-term memory loss long after being cleared by doctors to go back to their normal routines.

Matt Willis, Marin Countys public health officer, said he is still tired, weak, short of breath and has lingering circulation problems two months after his initial diagnosis.

I feel like my lungs have been traumatized by this, said Willis, who is not part of the UCSF study. Im still close enough to the illness that Im attributing some of these symptoms to post-viral inflammation.

But Henrich said some of these problems continue even after PCR, or polymerase chain reaction, tests no longer detect the virus, indicating an overzealous reaction by the human immune system.

We are seeing immune activation even after the PCR tests are negative, suggesting that the body has cleared the initial virus, but the immune response is ongoing for quite some time, he said. What we are interested in learning is: How long does this inflammation last, is there an ongoing immune activation?

Infectious disease specialists believe that many of the more severe symptoms, including ARDS, are being caused by overly robust immune responses to the infection.

The human immune response may also be responsible for an inflammatory reaction similar to Kawasaki disease that has recently been affecting children exposed to the coronavirus, according to a Centers for Disease Control and Prevention warning. Experts say the ailment, known as pediatric multisystem inflammatory syndrome, can cause rashes, fevers and heart inflammation more than a month after exposure to the virus.

Doctors at UCSFs Benioff Childrens Hospital have recently seen dozens of children with reddish-purple lesions on the feet and hands known as acral perniosis. The rashes all appeared weeks or months after exposure to adult relatives with flu-like symptoms, leading researchers to believe it is an after-the-fact inflammatory reaction to COVID-19.

Martin said the study at San Francisco General Hospital will test patients for antibodies and try to figure out what is going on with their immune responses. Researchers will also try to determine whether the 30 patients in the study have developed immunity and how long that immunity prevents them from being reinfected.

Morrison said the lingering fatigue, shortness of breath and blurred vision are concerns, but he is happy the phenomenon is being studied.

Were only four months into this pandemic, he said, and there is still so much that we dont know.

Peter Fimrite is a San Francisco Chronicle staff writer. Email: pfimrite@sfchronicle.com Twitter: @pfimrite

Read more from the original source:
Long after the illness is gone, the damage from coronavirus may remain - San Francisco Chronicle

Michelle Dockery (Defending Jacob) as a mother of teen son accused of murder: I thought this is going to be a tough challenge and I do love a…

Michelle Dockery, a four-time lead actress Emmy nominee for her performance as Lady Mary Crawley on PBS Downton Abbey and for the Netflix Western miniseries Godless, takes on a role that might be called a mothers worst nightmare on the crime miniseries Defending Jacob. The Apple TV+ program is based on the best-selling book by William Landay about a married couple whose 14-year-old son is charged with a stabbing death of a classmate who was bullying him.

The British actress says, For some reason for the last few years Ive been playing Americans much more. I enjoy it. I enjoy doing the accent. As she started to read the first three or four episode Defending Jacob scripts, she was hooked. She says, I thought this is going to be a tough challenge. And I do like a challenge. I was so enthralled by the journey of the family and what theyre all going through as a result of this tragedy.

In a scene where her wife and mother Laurie, who is wed to Andy Barber (Chris Evans), an assistant district attorney in Newton, Massachusetts, starts to doubt her sons innocence at a meeting with a psychiatrist while her husband becomes more convinced Jacob didnt do it, I thought all of this is getting really juicy now.

She believes that the show really touches on universal emotions of family and parents and children. I think that all parents out there will relate on some level. Theyll see traces of their hopes and anxieties in Andy and Laurie. I thought that was really interesting. I think were fascinated by human behavior, arent we? How well do you know your family? And how far would you go to protect them?

By the end of the series, Laurie is truly put through the wringer emotionally and physically as she suddenly learns that Andys father (J.K. Simmons) is serving a long prison sentence after killing and raping a woman when her husband was just a boy. The notion of a murder gene comes into play as it might exist in Jacob (Jaeden Martell). Dockery also had to jog in 100-degree heat as her character thinks she is being chased down by a strange man in a car and endures an devastating encounter in a grocery store.

SEEDefending Jacob showrunner Mark Bomback reveals origins of Chris Evans show [EXCLUSIVE VIDEO INTERVIEW]

There are few light moments in Defending Jacob, but there were some pleasures to be had for Dockery, especially the beautiful interior of the Barber family home with a spacious kitchen, a massive island, two sinks and tasteful decor. Laurie is an art major and obviously has great taste and there was great artwork around the house. When filming wrapped, I asked for a few of the prints, which I have in my home now.

Dockery goes on to speak about how well the citizens of Newton treated the cast and crew, how she enjoyed spending time in the Boston area since her father is Irish and if there will be a second big-screen Downton Abbey movie after the first gathered almost $200 million worldwide at the box office.

Be sure to make your Emmy nominations predictions today so that Hollywood insiders can see how their shows and performers are faring in our odds. You can keep changing your predictions as often as you like until just before the nominees are announced on July 28. And join in the thrilling debate over the 2020 Emmy Awards taking place right now with Hollywood insiders in our TV forums. Read more Gold Derby entertainment news.

SIGN UP for Gold Derbys free newsletter with latest predictions

View post:
Michelle Dockery (Defending Jacob) as a mother of teen son accused of murder: I thought this is going to be a tough challenge and I do love a...

Life of a finance head in the time of COVID-19 in Wallonia – Moneycontrol

Akash Ohri moved to the Seraing municipality in Liege province of Belgium as the Financial Controller for the industry sector at industrial machinery manufacturer John Cockerill Group in July 2019. The group, having a turnover of 1.3 billion euros, has five verticals and the industry sector is one of them.

For Ohri, this move from India to Belgium was a transfer within the company because of a shuffle of responsibilities. Ohri is a board member of the Indian subsidiary CMI Industry Automation and the Chinese joint venture Cockerill Engineering Beijing (CEB).

A professional with close to 20 years of experience, Ohri has been in Seraing alone these last few months. His family was supposed to join him in March in this scenic town close to the Belgian border but the travel bans due to COVID-19 threw a spanner in the works.

Associated with the industry vertical which largely deals with speciality metals and treatment, Ohri has seen overall demand collapse.

"All capex has been deferred to 2021. Clients have allowed us only 10-15% this year, mainly for design," he says.

This massive hit on revenues puts a question mark on the organisational structure, Ohri mulls. He is unsure how the fixed costs can be sustained as the sales teams are stuck.

"Though we are using Teams, Zoom and other tools, our sales need face-to-face meetings. We do not see the situation improving till mid-to end-June," he says.

It will be a slow road to recovery with different parts of the world in lockdown and the logistics of opening up has to be dealt with. He cites the example of a facility at Hedavali, Maharhastra.

"It is an open shed, yet it will require at least two days to open and restart it," he says.

Though China has opened up ahead of India, business is taking time.

"Even if we send someone to China, the person has to stay in quarantine for 14 days. We cannot sustain that kind of cost," he says.

China has a quarantine policy when people move from one type of risk zone to another. The company has a joint venture in Wuhan called Cockerill Engineering Wuhan (CEW).

As regards the rash of anti-China sentiment across the world, Ohri believes it is unlikely to persist as China is too closely interconnected with the world economy.

"Close to half the tourism revenue in Europe comes from China," he says.

However, the diversification of risk too is going to be a reality of the new world that will emerge after the pandemic dies. Simultaneously, he believes that India has a chance to attract fresh investments to itself provided it can find a way to cut through its famed red- tapism. He believes the Indian government is trying to do its best under the circumstances.

However, investors still do not have 100 percent confidence in the government because the administrative machinery below the top echelons is still what Ohri calls is "old machinery."

"The Prime Minister can say that (welcome) but what about the bureaucrats? All countries are linked now. It is no longer a closed circle," he says, speaking of the flow of investments in the post-COVID-19 world.

"There is no sure shot formula (out of the current mess). Nobody knows (how this will pan out)," he sayd.

Much will change in the future including human behavior, business models and consumer preferences.

"Definitely, travel will be avoided for sometime. I guess half the time, we will use tech for meetings. My guess is that at least a quarter of the workforce will be offered the option of work from home. In case of manufacturing there is no choice. We have to be on site," he says.

But Ohri does not expect the WFH to take root beyond a certain limit in India. "

"Indians like to talk face-to-face," he says.

He believes that the government will perhaps play a role in driving consumer behaviour towards more sustainable choices in the post-COVID-19 world. He is looking forward to the lifting of the last phase of the lockdown from June 8 in Belgium.

Belgium has reported one of the highest mortality rates for Covid-19, though its government says it is due to the rigour of counting. Belgium's Covid-19 lockdown began on March 18 but had significant relaxations as compared to the stringent Indian lockdown. It allowed offices to work with a third of the workforce.

Ohri stays mostly indoors barring a brisk walk in the morning and catches up with a couple of friends on Sundays. In a week, on Tuesdays and Thursdays he attends office just so that he can meet a couple of people. He drives around 11-odd kilometres to his office on the appointed days "so as to meet a couple of people" with the social distancing norms.

On the other days he works from home. Wednesdays and Fridays are his days of "economic unemployment" -- as 'solidarity' -- a concept where the company does not pay him for those two days, but the Belgian government covers the basic expenses.

After work, he goes for an evening walk as the sun sets as late as 9.30 PM in Seraing. Food is simple as he cooks himself for his vegetarian tastes. Thereafter, it is the usual video calls to family, friends and some television. Sundays, a couple of acquaintances meet to rule out the tedium. "There is a bit of homesickness. He is rethinking if his family should join him in Belgium now. His son was scheduled to join him, followed by his wife and daughter. Work and life will not be the same again.

"It will be a new world in 2021. And you have to welcome it. You have no choice," he says philosophically.

Moneycontrol Ready Reckoner

Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others.

Here is the original post:
Life of a finance head in the time of COVID-19 in Wallonia - Moneycontrol

What happened inside Jim Joyces brain the night Armando Galarraga lost his perfect game – Detroit Free Press

Let's look back at former Detroit Tigers pitcher Armando Galarraga's near-perfect game on June 2, 2010, at Comerica Park. Wochit

Massachusetts Institute of Technology neuroscience professor Earl Miller slowly nodded his head. A video of a baseball game from June 2, 2010, flashed across his computer screen,where first base umpire Jim Joyce botched the final out in what shouldve been the only perfect game in Detroit Tigers history.

"Yup, got it,"he said after watching the slow-motion replay. "I see it."

He didnt take long to analyze what happened inside Joyces brain, when the first-baseumpire botched Armando Galarragas perfect game by incorrectly calling Jason Donald safe at first baseon what should have been the final out.

Joyces mistake, Miller said, was a product of imperfect perception.

MIT neuroscience professor Earl Miller discusses what happened in Jim Joyce's brain the night Armando Galarraga lost his perfect game.(Photo: Evan Petzold, Detroit Free Press)

"Visual perception is a mix between what's actually going on and what you expect to see," said Miller, one of the nation'sleading experts on cognitive control, at The Picower Institute for Learning and Memory at MIT. "The two things collide and interact in our brain. You don't know what you see. You see what you expect to see. Our brains are so caught up in believing our own perception, and it's hard to deal with sometimes."

The brain doesnt work like a camcorder, he said.Our visual bandwidth is narrow, meaning only small amounts of information can be captured at a time.Because of this, the brain constantly tries to predict what will happen next.

[ Why Galarraga's game is 'perfect,' even if baseball will never call it that ]

Miller explains it as "expectation influencing reality."

"If you were sitting back without expectation because theres no motivation and nothing at stake, you might actually have a better perception of whats going on because of the lack of expectation,"Miller said. "Doing a job like this, where youre going to be under scrutiny and thousands of people are watching, that extra level of stress is going to amp up this mechanism."

Earl K. Miller, Picower Professor of Neuroscience at the Massachusetts Institute of Technology.(Photo: Massachusetts Institute of Technology)

More than 17,000 fans stood in excitement at Comerica Parkas Donald entered the batters box to face Galarraga with two outs in the top of the ninth inning, one out from the 21st perfect game in MLB history.

Joyce was in the middle of a high-stress situation, which could have cuedhisbrain to increase the power of the expectation mechanism. His desire to get thecall correct beyond a reasonable doubt ultimately led to the error, Miller said.

"Well, I guess anything's possible, but Im not that smart,"Joyce told the Free Press. "...All those things, subconsciously, Ill be honest with you, no, it really comes down to I missed the call. Its pretty simple."

[ Podcast: Looking back at Armando Galarraga's 'imperfect game,' 10 years later ]

The third pitch of the at-bat was a ground ball in the infield. First baseman Miguel Cabrera chased after it and stepped in front of second baseman Carlos Guillen to collect the ball. Galarraga raced to cover the bag.

The ball entered his glove.His foot touched first base.

A step later, Donald arrived.

"I really think that he saw out and signaled safe," former Tigers manager Jim Leyland told the Free Press. "I think he kind of froze, and I think he saw out, but he signaled safe, it was kind of like a mechanical thing. Now, I don't know if there's any truth to that, that's just what I thought."

Autoplay

Show Thumbnails

Show Captions

The "mechanical thing"Leyland questionscould be that Joyces vision of reality questioned his expectation. His right armtwitched toward signaling anout as if to portray uncertainty before using both arms to call the runner safe.

"It could be that he felt, 'Oh, this is an important play, and I just dont want to give it to the guy, so I better be sure.' Then, he sees it as an out when it really isnt an out, Miller said. "Its hard to say, just that he wanted it to be perfectly right because its such an important play. As a result, this expectation of extra scrutiny caused him to see the wrong thing."

And remember how far Cabrera had to range totrack down the ball? That might have something to do with all of this.

"If this umpire has seen a bunch of plays where the first baseman is way off to the side and the pitcher has to run over, and if on those plays the runner is often safe for that reason, thats going to build up this unconscious expectation that the runner will be safe,"Miller said. "If the first baseman wouldve stayed and the second baseman wouldve got the ball, thered be the expectation of an easy out. Thats going to influence perception."

The next batter grounded out, completing Galarragas "28-out perfect game" in a 3-0 win against the Cleveland Indians. Mayhem ensuedafter the final out. Galarraga hugged catcher Alex Avila, but his teammates rebuked Joyce on the field.

Even Leyland barked in his face.

Detroit Tigers manager Jim Leyland yells at first base umpire Jim Joyce, right, as umpires Jim Wolf (78), left, and home plate umpire Marvin Hudson (51), intervene after the Cleveland Indians lost 3-0 in Detroit on June 2, 2010. Tigers pitcher Armando Galarraga lost his bid for a perfect game with two outs in the ninth inning on the disputed call at first base.(Photo: Paul Sancya, Associated Press)

"I did not tell (Leyland) I missed the call,"Joyce told reporters after the game. "At that particular time, I really thought I got the call right."

Miller has no doubt about that.

He believes Joyce, based on his perception,trulysawthe runner touchthe base before Galarraga. But that's not to say he wasn't good at his job. Justdays later, he was named baseball's best umpire in a poll of 100 major-league players, according to ESPN The Magazine.

[ Jim Joyce, from Galarraga game, retires from MLB ]

"It doesnt matter how good you are," Miller said. "Everybodys perception is imperfect. Some people are more imperfect than others, some are better. Nobody is perfect. If you went back over calls like these over decades, youd find lots of mistakes."

Joyce watched the replay once he left the field, issued an emotional publicapologyand privately spoke with Galarraga. Theyquickly made amends, collaborated on a book and are now friends,but it's unlikely the call made by expectation influencing reality will ever be changed.

"And it all happens so fast, Miller said. "Split-second decisions are a killer."

Free Press sports writer Anthony Fenech contributed to this report.

Evan Petzold is a sports reporting intern at the Detroit Free Press. Contact him at epetzold@freepress.com or follow him on Twitter @EvanPetzold.

Read more here:
What happened inside Jim Joyces brain the night Armando Galarraga lost his perfect game - Detroit Free Press

Checking in with … Caelan Desmond (Williams) – News from southeastern Connecticut – theday.com

(Editor's note: The Day will be publishing a profile of a spring athlete for each day the high school athletic season is suspended.)

School: Williams School

Class: Senior

Sport: Sailing

Position: Skipper

College choice: Wesleyan University

Chosen major: Neuroscience on a pre-med track

Favorite high school class: Latin, it was a small class and I think that the environment fostered the most interesting conversations Ive had in my time at Williams.

Checking in with Caelan: "The Williams School has supported me academically and socially in ways incomparable to which I can imagine I would have gotten elsewhere. ... The community is incredibly tight and it is nice knowing that there will always be someone to stand by you when you need it."

What you need to know about Caelan: Because the varsity sailing team at Williams is only open to high school students, Desmond played lacrosse, basketball and soccer during her middle school years until she was permitted to sail. "I tried quite hard to weasel my way in there, but did not succeed," Desmond said. But sailing, which she has done competitively since she was 6, is Desmond's sport and she immediately earned a spot as a skipper her freshman year. "The Williams sailing team is so much fun and all of the sailors are passionate about the sport," she said. "This spring I was most looking forward to spending time with the team and enjoying the time we had on the boats. Since were all friends and sailing relies so heavily on learning from others, we work really well on the race course."Desmond, from Stonington, first began sailing at what is now New England Science & Sailing and is also a member of the Wadawanuck Club in Stonington. She was one of the first members of the locally based MudRatz youth sailing program and has competedwith them in Optimists, 420s, Melges 24s and J/70s, as well as sailing for the Special Olympics the last two years. "I love being out on the water and sailing has given me that while also giving me an outlet for competitiveness," Desmond said. "I find that I am able to bring things out onto the water and leave them there." She doesn't know if her ambitious academic undertaking will allow her to sail at Wesleyan, but she plans to return home to compete on occasion, including the Stonington Harbor Frostbite Series. Her favorite venue to sail has been at the Orange Bowl Regatta in Miami, which she attended in 2017, calling it "magical."

View original post here:
Checking in with ... Caelan Desmond (Williams) - News from southeastern Connecticut - theday.com

WVU and partners develop wearable biometric platform for early COVID-19 symptom prediction – Biometric Update

TheWest Virginia University Rockefeller Neuroscience Institute(RNI) andWVU Medicine in partnership with Oura Health have developed a biometric digital platform that detects COVID-19 symptoms three days before they are noticeable, the institute announced.

The system would be valuable in detecting asymptomatic individuals that carry the virus and inform them before they spread it in the community. To predict symptoms such as fever, coughing, breathing difficulties and fatigue, the platform leverages Oura Ring, a biometric wearable, and AI models that have over 90 percent accuracy, RNI claims.

The project to determine if Oura Rings worn by frontline healthcare workers could provide early COVID019 detection through tracking body temperature, heart rate and behavioral biometric assessments of stress and anxiety, memory, human resilience and recovery was launched just a few months ago.

The holistic and integrated neuroscience platform developed by the RNI continuously monitors the human operating system, which allows for the accurate prediction of the onset of viral infection symptoms associated with COVID-19,said Ali Rezai, M.D., executive chair of the WVU Rockefeller Neuroscience Institute, in a prepared statement. We feel this platform will be integral to protecting our healthcare workers, first responders, and communities as we adjust to life in the COVID-19 era.

The national study was launched in partnership with Oura Health with over 600 healthcare professionals and first responders taking part in the first phase. Other partners include Thomas Jefferson University in Philadelphia, Vanderbilt University in Nashville, and other institutions across West Virginia, New York City, and California. Future plans include expanding to over 10,000 participants.

Integration with AI models delivers real-time insights and predictions through 24/7 non-invasive and secure monitoring.

We are hopeful that Ouras technology will advance how people identify and understand our bodys most nuanced physiological signals and warning signs, as they relate to infectious diseases like COVID-19, said Harpreet Rai, CEO of Oura Health, in a prepared statement. Partnering with the Rockefeller Neuroscience Institute on this important study helps fulfill Ouras vision of offering data for the public good and empowering individuals with the personal insights needed to lead healthier lives.

The team is preparing for the second stage of the study by revealing the location of reported symptoms. The RNI app is available at WVUMedicine.org/RNI/COVID19.

AI | artificial intelligence | behavioral biometrics | biometric data | biometrics | data collection | fever detection | heartbeat | research and development | wearables

Go here to read the rest:
WVU and partners develop wearable biometric platform for early COVID-19 symptom prediction - Biometric Update

Reducing inflammation improves stroke recovery, may extend window for therapy – News-Medical.Net

Reviewed by Emily Henderson, B.Sc.Jun 1 2020

Reperfusion therapy, the gold standard for stroke treatment, helps restore blood flow after a stroke caused by a clot, preventing loss of brain tissue. However, only about 10% of stroke patients qualify, in part because of reperfusion therapy's narrow treatment window.

A recent Medical University of South Carolina study suggests that this therapy could be both safer and more effective for both motor and cognitive recovery if administered with a specialized compound that blocks the immune response. The team's preclinical findings, reported in the cover article of the May 13 Journal of Neuroscience, suggest that reducing the immune response in the brain could be a strategy for improving cognitive recovery. It could also extend the treatment window for therapy, allowing stroke specialists to help many more stroke patients.

With reperfusion therapy, we're restoring the blood flow, which is necessary to save the tissue, but there is an ongoing inflammatory response by the immune system that is not targeted by reperfusion."

Stephen Tomlinson, Ph.D., interim chair of the Department of Microbiology and Immunology at MUSC and senior author of the article

This could explain why, though mechanical reperfusion has a success rate of 90% in returning blood flow to the brain, only about 40% of treated patients recover enough motor and reasoning skills within three months to tend to their daily needs independently. Even those who do recover motor function can still struggle with cognitive challenges months later.

"I've seen patients who have barely any motor deficits at follow-up, but they're really struggling in their daily life in terms of memory, behavioral consequences and language," said lead author Ali Alawieh, M.D., Ph.D., who completed his graduate studies at MUSC and is now a resident in neurosurgery at Emory University School of Medicine.

Tomlinson and Alawieh think the immune response in the brain is the culprit.

During a stroke, the oxygen and energy supply to the brain is cut off by a clot, causing brain tissue to become stressed and die rapidly.

Just as it is with a cut to the knee, the immune system is activated to heal the wound, which includes clearing the dead tissue.

A family of special immune proteins called complement proteins help to guide and promote this immune response in the damaged areas.

In a 2018 article in Science Translational Medicine, Tomlinson and Alawieh showed that these complement proteins flagged both dead tissue and stressed brain cells for removal.

The stressed brain cells were not yet dead, only damaged by lack of oxygen and energy. As the goal of stroke treatment is to save as much brain tissue as possible to lessen overall damage, this was a concerning result, as it meant salvageable tissue was being destroyed by the immune system.

Therefore, Tomlinson and his team developed a complement protein blocker, named B4Crry, which acts only at the site of stroke injury. This compound blinds the complement proteins to the signals of stressed brain cells, saving the stressed tissue and reducing overall brain damage in a preclinical stroke model.

In the current study, Tomlinson and Alawieh hypothesized that pairing reperfusion therapy and B4Crry would significantly improve stroke recovery beyond reperfusion therapy alone. In particular, they hypothesized this combination treatment would improve cognitive recovery.

As Tomlinson's team expected, reperfusion therapy alone did improve recovery of coordinated movements such as walking in a preclinical model of stroke. With the addition of B4Crry to treatment, coordinated movement improved even faster, with greater recovery seen as early as three days after the stroke.

The improvements to learning and memory were even greater than those seen with motor functions.

Reperfusion therapy alone was equal to no treatment at all for learning and memory recovery after stroke. However, when B4Crry was added to their treatments, mice had greatly improved cognitive recovery, making three times fewer errors on a learning and memory task.

Tomlinson's team further probed into why the addition of B4Crry, and the subsequent reduction of the brain's immune response, aided cognitive recovery so greatly.

They found that after stroke, brain immune cells called microglia began eating the connections between stressed brain cells. Immune system complement proteins were marking these connections for destruction because they displayed the stressed cell signal. Without these connections, brain cells cannot communicate efficiently, and overall brain function decreases.

B4Crry concealed the cells' stress signals from the complement proteins and thereby saved the connections between neurons. Preserving connectivity improved learning and memory brain function after stroke.

A complement inhibitor such as B4Crry might also help stroke specialists overcome the biggest hurdle for reperfusion therapy: the short treatment window.

Tomlinson's team showed that after clot removal adding B4Crry to reperfusion therapy reduced the potential for hemorrhage, or excessive bleeding, even with treatment given up to six hours after the stroke. These findings suggest that complement inhibition could not only make reperfusion therapy safer but extend its treatment window, making it available for many more stroke patients.

Alawieh is excited about the future use of complement inhibition in the clinic.

"Our next step is to see how complement inhibitors work with comorbidities, such as old age, smoking and diabetes, in a preclinical study," he explained. "Collectively, this information will help us design the best clinical trial when we move to humans."

Tomlinson's team at MUSC is also testing the potential for complement inhibitors in other brain injuries, such as traumatic brain injury.

"We have shown that we can administer complement inhibitors as far as two months after a traumatic brain injury and see improvements in cognitive recovery," said Tomlinson. "This is something I'm actually quite excited about. It means that months after an initial event, complement inhibitors could still be beneficial to cognitive recovery after brain injuries, including strokes."

Source:

Journal reference:

Alawieh, A.M., et al. (2020) Complement-Dependent Synaptic Uptake and Cognitive Decline after Stroke and Reperfusion Therapy. Journal of Neuroscience. doi.org/10.1523/JNEUROSCI.2462-19.2020.

Original post:
Reducing inflammation improves stroke recovery, may extend window for therapy - News-Medical.Net

Ehave, Inc. Adds Adviser For Clinical Trials For Its Cognitive And Psychedelic Opportunities To Medical Advisory Board – GlobeNewswire

MIAMI, June 01, 2020 (GLOBE NEWSWIRE) -- Ehave, Inc., (OTC Pink: EHVVF) (the Company), a provider of digital therapeutics delivering evidence-based therapeutic interventions to patients, announced neuroscience researcher, Dr. Nithin Krishna, M.D., has consented to join the Company's Medical Advisory Board. As a member of the Companys Medical Advisory Board, Dr. Nithin Krishnas main responsibilities will be to assist and advise the Company on human trials for its cognitive and psychedelic opportunities.

Dr. Krishna is currently in private practice at Psych Associates of Maryland. Psych Associates specializes in behavioral health services, including psychological testing and neuropsychological testing for a variety of disorders, including ADHD, brain injuries and head trauma, and memory problems. He boasts an extensive publication list and an impressive resume of original scientific findings. Dr. Krishna completed his postdoctoral program at the University of Maryland School of Medicine, Maryland Psychiatric Research Center in Baltimore, Maryland continuing on through the University of Maryland/Sheppard Pratt Psychiatry Residency Training Program research track. Dr. Krishna is board certification by the American Board of Psychiatry and Neurology. In addition to his work as a clinician, he conducts research in psychiatry and neuroscience with expertise in genetics, electroencephalogram (EEG), schizophrenia, psychotic disorders, suicide and cranial electric stimulation.

"Dr. Krishna is recognized as an expert in both Psychological and neuropsychological testing," said Ben Kaplan, CEO of Ehave, Inc. "His research in the areas of ADHD, brain injuries, head trauma, and memory problems has been his passion. Most importantly, in recent years Dr. Krishna has worked tirelessly to provide superior healthcare to his patients. We are very fortunate to welcome an individual like Dr. Krishna to our medical advisory board and look forward to collaborating with him as we continue to pave the way for the psychedelic medical industry."

About Ehave, Inc.

Ehave, Inc. is a provider of digital therapeutics delivering evidence-based therapeutic interventions to patients. Our primary focus is on improving the standard care in therapeutics to prevent or treat brain disorders or diseases through the use of digital therapeutics, psychedelics, independently or together, with medications, devices, and other therapies to optimize patient care and health outcomes meeting privacy and HIPAA & GDPR Compliant. Our main product is the Ehave Dashboard which is a mental health informatics platform that allows clinicians to make objective and intelligent decisions through data insight using Blockchain technology. The Ehave dashboard offers Offline Encrypted Digital Records Empowering Healthcare providers and patients and it's a powerful machine learning and artificial intelligence platform using artificial intelligence to extract deep insights from audio, video and text to improve research with a growing set of advanced tools and applications developed by Ehave and its leading partners. This empowers patients, healthcare providers, and payers to address a wide range of conditions through high quality, safe, and effective data-driven involvement with intelligent and accessible tools.

Forward-Looking Statement Disclaimer

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may be preceded by the words intends, may, will, plans, expects, anticipates, projects, predicts, estimates, aims, believes, hopes, potential or similar words. Forward-looking statements are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company's control, and cannot be predicted or quantified and consequently, actual results may differ materially from those expressed or implied by such forward-looking statements: (i) the initiation, timing, progress and results of the Companys research, manufacturing and other development efforts; (ii) the Companys ability to advance its products to successfully complete development and commercialization; (iii) the manufacturing, development, commercialization, and market acceptance of the Companys products; (iv) the lack of sufficient funding to finance the product development and business operations; (v) competitive companies and technologies within the Companys industry and introduction of competing products; (vi) the Companys ability to establish and maintain corporate collaborations; (vii) loss of key management personnel; (viii) the scope of protection the Company is able to establish and maintain for intellectual property rights covering its products and its ability to operate its business without infringing the intellectual property rights of others; (ix) potential failure to comply with applicable health information privacy and security laws and other state and federal privacy and security laws; and (x) the difficulty of predicting actions of the USA FDA and its regulations. All forward-looking statements included in this press release are made only as of the date of this press release. The Company assumes no obligation to update any written or oral forward-looking statement unless required by law. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is contained under the heading "Risk Factors" in Ehave, Inc.s Registration Statement on Form F-1 filed with the Securities and Exchange Commission (SEC) on September 24, 2015, as amended, which is available on the SEC's website, http://www.sec.gov.

For Investors Relations, please contact:

Gabe Rodriguez

Phone: (623) 261-9046

Email: ir@ehave.com

More:
Ehave, Inc. Adds Adviser For Clinical Trials For Its Cognitive And Psychedelic Opportunities To Medical Advisory Board - GlobeNewswire

Tap Into Emotion to Meet Learning Objectives – ATD

Deliver an engaging, effective learning experience by leveraging the power of emotion.

The late great author and lecturer Dale Carnegie famously said, "When dealing with people, remember you are not dealing with creatures of logic, but with creatures of emotion." Perhaps nowhere is that more applicable than when it comes to learning. Individuals are more likely to remember stories and events when they connect with them on an emotional level. Everyone can probably recall specific events, personal or otherwise, that have moved them in some way. Using the power of emotion in learning can have a strong impact on learning effectiveness, retention, and outcomes.

Advertisement

Learning can be an emotional process: People naturally remember events and experiences that make them feel something emotionally. Emotion greatly affects learning, memory, and performance; savvy learning experience designers tap into that. By designing experiences that invoke emotionseither positive or negativethere is a greater chance that learners will take notice of and encode, store, and retrieve the information when needed. Essentially, it's about making things stick.

There are many books about motivation, but how do instructional designers develop a personalized, scalable learning experience for people who have different drivers and habits? Individuals will have their own reasons for acting, so when creating learning experiences, seek out common ground. That is where emotion comes in.

For most people, a poignant story or event will elicit a similar emotional response, demonstrating why emotion is such an effective lever for learning. Rather than trying to motivate people to do something, think about how you can make them feel something.

While there are many behavioral science concepts with practical applications in corporate L&D, there are a few particularly powerful techniques every learning experience creator should be familiar with and integrate into their learning strategy. By understanding the role of emotion in learningand helping your learners form an emotional connection with the learning content you're presentingyou can more effectively engage learners and improve the quality of their learning experiences.

Create a learning experience that taps into learners' emotions to maximize learning impact and retention.

Consider the emotions you want to evoke. Think carefully about the emotions you want to elicit among your learners. Drawing on core emotionssuch as fear, anger, joy, surprise, sadness, and even disgustcan make learning stickier and more engaging. And while you don't want to use negative emotions excessively, and you certainly don't want to create a culture of fear when it comes to learning, even negative emotions can have a place and a purpose in your design.

When you're buying or creating learning content, think critically about whether the learning experience will engage your audience and elicit an emotional reaction. An emotional reaction is more likely to trigger a lasting memory.

Motivate learners using loss aversion. Losing is an emotional experience. The world of behavioral science, specifically psychologists Amos Tversky and Daniel Kahneman, reveals that people feel a loss about twice as strongly as they feel a gain.

Game designers love to exploit that irrational human trait to engage players and get them to feel things as they play along. Some people may even argue that a game isn't a game at all unless there's a chance a player loses. Leveraging gamification techniques, such as awarding points that employees must actively work to keep, can be a particularly powerful learning strategy.

Make use of social stories. Humans are social creatures. As such, people are constantly asking themselves questions like "How will this make me look?" and "What are other people doing?"

On some level, everyone cares about what others think. And from the explosive rise of reality television and social media, it's easy to see that people also find others' stories and experiences downright fascinating. By using real-world stories and situations to harness and engage this natural social drive that everyone possesses, you can create an emotional learning experience to make learning more memorable and effective.

Link emotion to the topic and the learner's actions. While experiencing an emotion helps people remember relevant information, it's not enough to invoke a disconnected emotion in learners. To be effective, the emotion you want to trigger must have a clear link to the topic. Essentially, it's the "so what" factor.

Learners should be asking themselves questions like "Why should I care about this topic?" and "What will I do differently as a result of the experience?" So, don't just make learners feel sad or afraid; rather, help them make the right connections and choices.

Triggering an emotion can create a lasting and powerful effect when it comes to encoding long-term memories. If learners identify with the character in a scenario, for example, they are more likely to have an emotional response if that character suffers consequences from their poor choices.

Learners are more likely to remember something if it's tied to an emotion. That's why drawing on design approaches such as dramatic storytelling, gamification, and interactive video can be incredibly effective when it comes to creating memorable learning experiences. Even music plays a key part in provoking emotions that will have lasting impact. By harnessing the power of emotion, instructional designers can create the best learning experience for learners, helping them upskill and reskill quickly.

Tversky, A., and D. Kahneman. 1992. "Advances in Prospect Theory: Cumulative Representation of Uncertainty." Journal of Risk and Uncertainty, 5 (4): 297-323.

Immordino-Yang, M.H. 2016. Emotions, Learning, and the Brain: Exploring the Educational Implications of Affective Neuroscience (The Norton Series on the Social Neuroscience of Education), 1st edition. New York, NY: W.W. Norton & Co.

Saba. n.d. "Using Neuroscience Principles to Power Learning - A Guide to Success." http://www.saba.com/resources/ebooks-and -guides/using-neuroscience-principles-to-power-learning-a-guide-to-success.

Here is the original post:
Tap Into Emotion to Meet Learning Objectives - ATD